SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K was filed by BioSig Technologies, Inc. on July 14, 2022. The registrant is incorporated in Delaware and its common stock trades on The NASDAQ Capital Market under the symbol BSGM. The report addresses a regulatory notice received from the Nasdaq Listing Qualifications Department regarding the company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance: the closing bid price of the common stock remained below the $1.00 minimum requirement for 30 consecutive business days between May 31, 2022, and July 13, 2022.
Material Changes and Listing Status
The primary material event is the failure to satisfy Nasdaq Listing Rule 5550(a)(2) due to the minimum bid price deficiency. Consequently, the company has been granted a compliance period of 180 calendar days, ending January 10, 2023, to regain compliance. To cure the deficiency, the stock must maintain a minimum closing bid price of $1.00 for at least ten consecutive business days during this period. The filing states there is no immediate impact on the listing, and trading will continue subject to other requirements.
Outlook, Risks, and Contingencies
If the company fails to regain compliance by the end of the initial period, it may be eligible for an additional 180-day compliance period. Qualification for this extension requires meeting the market value of publicly held shares and all other initial listing standards, potentially necessitating a reverse stock split. If the company cannot cure the deficiency or is deemed ineligible for an extension, Nasdaq will issue a notice of delisting.
Investor Verification Checklist
- Verify the current closing bid price of BSGM to assess progress toward the $1.00 threshold.
- Monitor the company's announcement of a reverse stock split if the initial compliance period expires without meeting the price requirement.
- Check for any subsequent Nasdaq communications regarding the extension of the compliance period or delisting notices.
- Review the company's market value of publicly held shares to determine eligibility for the second compliance period.